Related Experiment Video
Updated: Jul 7, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Co-infections in COVID-19 patients and correlation with mortality rate. Minireview
Ágnes Fehér1, Zsófia Szarvas1, Andrea Lehoczki2
11 Department of Public Health, Semmelweis University, Faculty of Medicine, Budapest, Hungary.
Insights
Co-infections in COVID-19 patients, particularly bacterial and fungal, worsen outcomes and increase mortality, especially in hospitals. Risk factors include male gender and intensive care. (31 words)
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) poses significant public health challenges.
- Co-infections complicate COVID-19 patient management and outcomes.
- Understanding co-infection patterns is crucial for effective treatment strategies.
Purpose of the Study:
- To identify key community- and hospital-acquired co-infections in COVID-19 patients.
- To analyze the impact of co-infections on COVID-19 disease severity and outcomes.
- To determine risk factors predisposing COVID-19 patients to co-infections.
Main Methods:
- Systematic literature search of Medline (PubMed) and Google Scholar.
- Inclusion of articles published between January 1, 2020, and September 31, 2021.
- Focus on co-infections in patients diagnosed with COVID-19.
Main Results:
- Bacterial and fungal co-infections were most frequent, followed by viral co-infections.
- Co-infections were more prevalent in hospitalized patients compared to community settings.
- Risk factors included male gender, prolonged hospitalization, mechanical ventilation, ICU admission, steroid/antibiotic use, high C-reactive protein, and lymphopenia.
Conclusions:
- Co-infections can exacerbate COVID-19 severity, prolong recovery, and increase mortality, particularly in hospital settings.
- Enhanced hygiene, adherence to protocols, and antimicrobial stewardship are vital.
- Implementing these measures can reduce co-infection rates and improve patient outcomes.
Purpose:
The goal of our review was to gather information on the most important community-acquired and hospital-acquired co-infections among coronavirus disease 2019 (COVID-19) patients, and to examine not only the effect of these co-infections on disease outcomes but also to identify the possible risk factors that predispose COVID-19 patients to co-infections.
Methods:
Medline (PubMed) and Google Scholar were searched for relevant articles published between January 1st, 2020, and September 31st, 2021, on the topic of co-infections among COVID-19 patients.
Results:
Among community-acquired and hospital-acquired co-infections, bacterial and fungal co-infections are equally frequent, followed by viral co-infections that affected a relatively smaller portion of patients. Overall, co-infections were more frequent in the hospital than at the community level. Risk factors for acquiring co-infections include male gender, longer length of hospital stay, presence of supportive treatment, such as ventilation, the admission to intensive care units, the administration of medications, such as steroids or antibiotics, and certain blood parameters, such as high C-reactive protein or lymphopenia. The presence of co-infections could aggravate the COVID-19 disease severity, prolong the healing time of patients, and lead to worse disease outcomes overall.
Conclusion:
Co-infections may increase the mortality of COVID-19 patients, especially in the hospital setting. Paying closer attention to hygiene, adhering to diagnostic and therapeutic protocols, implementing antimicrobial stewardship programs could decrease the occurrence of co-infections and lead to improved outcomes for COVID-19 patients.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
03:53Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Infectious Diseases and Their Occurrence